TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
RLAY

Relay Therapeutics Inc

Healthcare · Biotechnology

18.00$ -6.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

Relay Therapeutics Inc (RLAY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 0.4 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RLAY
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
25 0.0 10 0.0 0.0 0.0 7.7 0.7 0.0 7.0 3.0 0.4 10
81 74 82 92 77 64 – 61 68 0.6 0.5 – –
-56 -74 -72 -92 -77 -64 7.7 -61 -68 6.4 2.5 0.4 -59
81 77 82 92 77 68 74 64 68 55 71 76 271
18 16 20 20 20 16 19 14 12 13 11 15 51
17 18 18 8.8 20 21 93 16 13 67 81 91 252
-74 -92 -90 -101 -96 -85 -85 -77 -80 -61 -79 -91 -310
– 6.9 – – – – – – – – – – –
-66 -83 -81 -92 -88 -76 -77 -70 -74 -55 -73 -84 -286
-1.4 18 1.4 – – – – – – – – – –
-66 -83 -81 -92 -88 -76 -77 -70 -74 -55 -73 -84 -286
-73 -93 -91 -111 -87 -75 -76 -69 -73 -58 -73 -83 -287

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?